Stock AVCT AVACTA GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Avacta Group Plc

Equities

AVCT

GB00BYYW9G87

Market Closed - London S.E.
Other stock markets
 11:35:07 2024-06-06 am EDT 		5-day change 1st Jan Change
41.25 GBX +0.61% Intraday chart for Avacta Group Plc -1.08% -64.59%
May. 23 Windward wins deal; Kodal progresses at Bougouni AN
May. 23 Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avacta picks Christina Coughlin to replace long-serving CEO
AN
Avacta Group CEO Steps Down; Successor Appointed
MT
Avacta Group plc Announces Chief Executive Officer Changes
CI
Avacta says new head of R&D Coughlin brings "deep expertise"
AN
Avacta Group plc Announces Appointment of Christina Coughlin as Head of Research and Development and Resignation of Fiona Mclaughlin as Chief Scientific Officer
CI
Avacta taps biopharma veteran as Therapeutics business chief
AN
Avacta Group plc Appoints Simon Bennett as Chief Business Officer of the Therapeutics Division
CI
Capital inks contract; Lansdowne becomes cash shell
AN
Avacta Group Plc Announces Management Changes
CI
Avacta Group plc Appoints Shaun Chilton to the Board as Non-Executive Director
CI
FTSE 100 Closes Down 0.3% as Economic Outlook Concerns Drag
DJ
Avacta Group Plc Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division
CI
Avacta Appoints Dr Christina Coughlin as Non-Executive Director
CI
Avacta Group plc Announces New Appointments to Scientific Advisory Board
CI
Avacta : Names Chief Scientific Officer For Therapeutics Unit
MT
Avacta Group plc Appoints Fiona McLaughlin as Chief Scientific Officer of Therapeutics Division
CI
Avacta Appoints Mark Goldberg as Non-Executive Director
CI
Mike Owen Steps Down from Avacta Group plc as Non-Executive Director, with Effect from 24 March 2021
CI
Avacta Group plc Appoints Neil Bell as Chief Development Officer of Avacta Life Sciences
CI
Avacta Group plc Appoints Paul Fry as Non Executive Director with Effect from 3 February 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVCT Stock
  4. News Avacta Group Plc
  5. Insiders